Table 4. The single nucleotide polymorphisms (SNPs) predictive of the subjects with 15% lowest and highest IMT changes from 2001 to 2007.

SNP ID* (rs number)	Gene symbol (HGNC name)	SNP location (Chr region)	Significance† (p-value)	Predictive power‡ (%AUC)
rs2073658	USF1	1q23.3	0.70	9.40
rs9479055	C6orf97	6qs25.1	0.40	8.55
rs17672135	FMN2	1q43	0.41	8.55
rs9687339	MAST4	5q12.3	0.93	7.69
rs1042713	ADRB2	5q33.1	0.48	7.69
rs2301880	WNK1	12p13.33	1.00	6.84
rs3130340	INTERGENIC	6p21.32	0.11	6.84
rs2476601	PTPN22	1p13.2	0.44	5.13
rs11898505	SPTBN1	2p16.2	0.27	5.13
rs3798220	LPA	6q25.3	1.00	5.13
rs10172036	ICOS	2q33.2	0.52	5.13
rs2820037	INTERGENIC	1q43	0.66	4.27
rs2234693	ESR1	6q25.1	0.74	3.42
rs1800896	IL10	1q32.1	0.71	3.42
rs17222814	ALOX5AP	13q12.3	0.89	3.42
rs1801274	FCGR2A	1q23.3	0.75	2.56
rs854560	PON1	7q21.3	0.81	1.71
rs10246939	TAS2R38	7q34	0.80	1.71
rs9594738	INTERGENIC	13q14.11	0.58	1.71
rs1799983	NOS3	7q36.1	0.06	0.855
rs1256049	ESR2	14q23.2	0.46	0.855

*The SNPs identified also in the previous case-control association studies [9]–[21] are boldfaced.

†The corrected p-values larger than one were truncated to unity.

‡The SNPs are arranged according to their contribution to the overall prediction accuracy (AUC).